Clinical trial · Interventional
Expanding Rural Health Cancer Control Capacity
Expanding Rural Health Cancer Control Capacity: Focus on Cancer Survivorship
NCT04765072CI-TRIAL-00082601active not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Through this pilot study, investigators will test an innovative approach to implement survivorship care planning at three sites located in or adjacent to rural counties. The pilot data will inform a subsequent multi-site Hybrid Type 3 Implementation-Effectiveness study that will assess both implementation and clinical effectiveness outcomes.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Survivorship Patient Navigation Intervention | Behavioral | — | UNRESOLVED |
| Telehealth Survivorship Visit Intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Survivorship care
- description
- Participants in rural areas will receive a telehealth (providing health-related services through electronic communication technologies) survivorship care plan in combination with assistance from a patient navigator.
- interventionNames
- Behavioral: Survivorship Patient Navigation Intervention
- Behavioral: Telehealth Survivorship Visit Intervention
Primary outcomes (4)
- measure
- Rate of improvement in adherence to survivorship plan (Survivorship Care Planning Experience Satisfaction Survey (1-5 Excellent - Poor)
- timeFrame
- Approximately 12 months
- measure
- Measure effectiveness of Telehealth on survivorship care
- timeFrame
- Approximately 12 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Cancer patient at least 18 years of age at time of cancer therapy * English-speaking with the ability to provide informed consent * Received treatment for Stage 0 - III cancer with curative intent * Completed cancer therapy within the previous 12 months (i.e., 12 months prior to consenting) and in complete remission
References
Publications (0)
Data not yet available
No reference posted for this study.